Digital Automation And Analytics: Enabling The Future Of Intensified Biomanufacturing

As biopharmaceutical manufacturers pursue process intensification (PI) to boost productivity and reduce costs, they face mounting complexity in operations, control, and compliance. This white paper explores how a robust digital infrastructure—spanning automation, orchestration, and predictive analytics—is essential to realizing the full potential of PI. It outlines the challenges of coordinating continuous operations, maintaining real-time visibility, and scaling from development to commercial production. Explore how Sartorius’ modular digital ecosystem, including Biobrain® and Umetrics® Digital Twin AI, enables synchronized, data-driven manufacturing across diverse systems and vendors. With built-in compliance features and support for open standards like OPC UA, the platform simplifies integration, accelerates deployment, and supports real-time release strategies.
Learn how digital transformation can unlock the next generation of biomanufacturing.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.